ERcast: Clinical Perspectives Podcast Preview

Subscription Required

Lit Matters #1 - Single vs Serial Troponin in ED Chest Pain

Salim Rezaie, MD and Matthew DeLaney, MD, FACEP, FAAEM

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Low-risk ED chest pain can often be ruled out without prolonged observation. In community emergency departments using a conventional troponin assay, a single negative troponin paired with HEART score risk stratification had the same 30-day rate of myocardial infarction or cardiac death as serial testing.

Single vs Serial Troponin

  • HEART-guided discharge strategy: A low-risk HEART score was the key companion to a single negative conventional troponin, framing this as selective risk stratification rather than a shortcut.
  • Matched 30-day safety signal: Thirty-day myocardial infarction or cardiac mortality after ED discharge was 0.4% in both the single-troponin and serial-troponin groups.
  • Conventional assay relevance: These results came from a contemporary conventional troponin-I assay, making the question especially relevant to departments not using high-sensitivity troponin.
  • Low yield of repeat testing: Only 66 patients in the serial-testing cohort had a subsequent positive troponin, suggesting the second draw changed management infrequently. We get into the practice implications in the episode.
  • Timing caveat: Symptom-onset timing was not available in the dataset, an important limitation because early presenters are the group most likely to benefit from serial sampling.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

Faculty